Swindells Mark B, Porter Craig T, Couch Matthew, Hurst Jacob, Abhinandan K R, Nielsen Jens H, Macindoe Gary, Hetherington James, Martin Andrew C R
Chemogenomix, 12 High Street, Easton on the Hill PE9 3LR, UK.
Institute of Structural and Molecular Biology, Division of Biosciences, University College London, Gower Street, London WC1E 6BT, UK.
J Mol Biol. 2017 Feb 3;429(3):356-364. doi: 10.1016/j.jmb.2016.08.019. Epub 2016 Aug 22.
abYsis is a web-based antibody research system that includes an integrated database of antibody sequence and structure data. The system can be interrogated in numerous ways-from simple text and sequence searches to sophisticated queries that apply 3D structural constraints. The publicly available version includes pre-analyzed sequence data from the European Molecular Biology Laboratory European Nucleotide Archive (EMBL-ENA) and Kabat as well as structure data from the Protein Data Bank. A researcher's own sequences can also be analyzed through the web interface. A defining characteristic of abYsis is that the sequences are automatically numbered with a series of popular schemes such as Kabat and Chothia and then annotated with key information such as complementarity-determining regions and potential post-translational modifications. A unique aspect of abYsis is a set of residue frequency tables for each position in an antibody, allowing "unusual residues" (those rarely seen at a particular position) to be highlighted and decisions to be made on which mutations may be acceptable. This is especially useful when comparing antibodies from different species. abYsis is useful for any researcher specializing in antibody engineering, especially those developing antibodies as drugs. abYsis is available at www.abysis.org.
abYsis是一个基于网络的抗体研究系统,它包含一个抗体序列和结构数据的集成数据库。该系统可以通过多种方式进行查询——从简单的文本和序列搜索到应用三维结构约束的复杂查询。公开版本包括来自欧洲分子生物学实验室欧洲核苷酸档案库(EMBL-ENA)和卡巴特的预先分析的序列数据以及来自蛋白质数据库的结构数据。研究人员自己的序列也可以通过网络界面进行分析。abYsis的一个显著特点是,序列会自动按照一系列常用方案(如卡巴特和乔西亚方案)进行编号,然后用关键信息(如互补决定区和潜在的翻译后修饰)进行注释。abYsis的一个独特之处是针对抗体中每个位置的一组残基频率表,这使得“异常残基”(即在特定位置很少出现的残基)能够被突出显示,并对哪些突变可能是可接受的做出决策。这在比较不同物种的抗体时特别有用。abYsis对任何专门从事抗体工程的研究人员都很有用,尤其是那些将抗体开发为药物的研究人员。可在www.abysis.org上获取abYsis。